Susquehanna International Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-108,832
| Closed | -$4.45M | – | 6818 |
|
|
2024
Q2 | $4.45M | Sell |
108,832
-4,760
| -4% | -$195K | ﹤0.01% | 1096 |
|
|
2024
Q1 | $4.8M | Sell |
113,592
-31,823
| -22% | -$1.35M | ﹤0.01% | 1050 |
|
|
2023
Q4 | $6.17M | Buy |
145,415
+118,696
| +444% | +$5.03M | ﹤0.01% | 1010 |
|
|
2023
Q3 | $583K | Sell |
26,719
-6,934
| -21% | -$151K | ﹤0.01% | 3215 |
|
|
2023
Q2 | $1.07M | Sell |
33,653
-65,627
| -66% | -$2.09M | ﹤0.01% | 2627 |
|
|
2023
Q1 | $2.42M | Buy |
99,280
+76,500
| +336% | +$1.87M | ﹤0.01% | 1758 |
|
|
2022
Q4 | $718K | Sell |
22,780
-35,043
| -61% | -$1.11M | ﹤0.01% | 2739 |
|
|
2022
Q3 | $1.63M | Buy |
57,823
+50,194
| +658% | +$1.42M | ﹤0.01% | 1889 |
|
|
2022
Q2 | $202K | Sell |
7,629
-26,340
| -78% | -$697K | ﹤0.01% | 4554 |
|
|
2022
Q1 | $1.19M | Sell |
33,969
-46,694
| -58% | -$1.63M | ﹤0.01% | 2597 |
|
|
2021
Q4 | $2.62M | Buy |
80,663
+36,009
| +81% | +$1.17M | ﹤0.01% | 1699 |
|
|
2021
Q3 | $1.32M | Buy |
44,654
+30,092
| +207% | +$888K | ﹤0.01% | 2432 |
|
|
2021
Q2 | $373K | Sell |
14,562
-173,726
| -92% | -$4.45M | ﹤0.01% | 4237 |
|
|
2021
Q1 | $2.59M | Buy |
188,288
+165,788
| +737% | +$2.28M | ﹤0.01% | 1832 |
|
|
2020
Q4 | $373K | Buy |
+22,500
| New | +$373K | ﹤0.01% | 3698 |
|